- Home
- PMF vs GNFT Comparison
PMF vs GNFT Comparison
Compare PMF & GNFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMF
- GNFT
- Stock Information
- Founded
- PMF 2001
- GNFT 1999
- Country
- PMF United States
- GNFT France
- Employees
- PMF N/A
- GNFT N/A
- Industry
- PMF Finance/Investors Services
- GNFT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PMF Finance
- GNFT Health Care
- Exchange
- PMF Nasdaq
- GNFT Nasdaq
- Market Cap
- PMF 249.4M
- GNFT 249.0M
- IPO Year
- PMF N/A
- GNFT 2019
- Fundamental
- Price
- PMF $10.10
- GNFT $5.51
- Analyst Decision
- PMF
- GNFT Strong Buy
- Analyst Count
- PMF 0
- GNFT 1
- Target Price
- PMF N/A
- GNFT $13.00
- AVG Volume (30 Days)
- PMF 61.3K
- GNFT 20.7K
- Earning Date
- PMF 01-01-0001
- GNFT 09-19-2024
- Dividend Yield
- PMF 5.36%
- GNFT N/A
- EPS Growth
- PMF N/A
- GNFT N/A
- EPS
- PMF N/A
- GNFT 0.47
- Revenue
- PMF N/A
- GNFT $86,225,222.00
- Revenue This Year
- PMF N/A
- GNFT $155.44
- Revenue Next Year
- PMF N/A
- GNFT N/A
- P/E Ratio
- PMF N/A
- GNFT $11.67
- Revenue Growth
- PMF N/A
- GNFT 175.45
- 52 Week Low
- PMF $7.69
- GNFT $2.97
- 52 Week High
- PMF $10.56
- GNFT $6.05
- Technical
- Relative Strength Index (RSI)
- PMF 60.19
- GNFT 66.56
- Support Level
- PMF $10.03
- GNFT $5.12
- Resistance Level
- PMF $10.50
- GNFT $6.05
- Average True Range (ATR)
- PMF 0.14
- GNFT 0.31
- MACD
- PMF -0.01
- GNFT 0.04
- Stochastic Oscillator
- PMF 37.16
- GNFT 87.37
About PMF PIMCO Municipal Income Fund
PIMCO Municipal Income Fund is a closed-end management investment company. Its primary investment objective is to seek to provide current income exempt from federal income tax. The fund invests a majority of its net assets in municipal bonds that pay interest that is exempt from federal income tax.
About GNFT GENFIT S.A.
Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.